120 related articles for article (PubMed ID: 20479294)
1. High-dose treatment with vitamin A analogues and risk of fractures.
Vestergaard P; Rejnmark L; Mosekilde L
Arch Dermatol; 2010 May; 146(5):478-82. PubMed ID: 20479294
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk in users of oral anticoagulants: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Int J Cardiol; 2007 Jun; 118(3):338-44. PubMed ID: 17055083
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate, azathioprine, cyclosporine, and risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):69-75. PubMed ID: 16927044
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Azoulay L; Oraichi D; Bérard A
Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
[TBL] [Abstract][Full Text] [Related]
6. Decreased fracture risk in users of organic nitrates: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Bone Miner Res; 2006 Nov; 21(11):1811-7. PubMed ID: 17054422
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark.
Vestergaard P; Rejnmark L; Mosekilde L
Scand J Public Health; 2006; 34(4):371-7. PubMed ID: 16861187
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and risk of fractures.
Vestergaard P; Rejnmark L; Mosekilde L
Contraception; 2006 Jun; 73(6):571-6. PubMed ID: 16730486
[TBL] [Abstract][Full Text] [Related]
9. Reduced fracture risk in users of thiazide diuretics.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2005 Mar; 76(3):167-75. PubMed ID: 15719207
[TBL] [Abstract][Full Text] [Related]
10. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
[TBL] [Abstract][Full Text] [Related]
11. Fracture risk associated with the use of morphine and opiates.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2006 Jul; 260(1):76-87. PubMed ID: 16789982
[TBL] [Abstract][Full Text] [Related]
12. [Aggravation of acne by isotretinoin. 6 cases, predictive factors].
Lehucher Ceyrac D; Chaspoux C; Sulimovic L; Morel P; Lefrancq H
Ann Dermatol Venereol; 1998 Aug; 125(8):496-9. PubMed ID: 9747314
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2008 Apr; 82(4):249-57. PubMed ID: 18414920
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk in patients treated with loop diuretics.
Rejnmark L; Vestergaard P; Mosekilde L
J Intern Med; 2006 Jan; 259(1):117-24. PubMed ID: 16336519
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
[TBL] [Abstract][Full Text] [Related]
16. Osteoarthritis and risk of fractures.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2009 Apr; 84(4):249-56. PubMed ID: 19234808
[TBL] [Abstract][Full Text] [Related]
17. Reduced relative risk of fractures among users of lithium.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2005 Jul; 77(1):1-8. PubMed ID: 16007481
[TBL] [Abstract][Full Text] [Related]
18. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
19. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
